What is ZeroSweat?
ZeroSweat operates at the intersection of consumer health and personal hygiene, providing targeted antiperspirant solutions for individuals managing excessive sweating. By offering a diverse product portfolio that includes roll-ons, lotions, wipes, and underarm pads, the company addresses a critical pain point for a niche yet substantial demographic. Their value proposition is anchored in clinical efficacy, promising up to seven days of dryness per application. As an FDA-compliant entity, ZeroSweat distinguishes itself through rigorous quality standards and a consumer-centric risk-free guarantee, positioning the brand as a reliable authority in the hyperhidrosis treatment sector.
How much funding has ZeroSweat raised?
ZeroSweat has raised a total of $11K across 1 funding round:
Debt
$11K
Debt (2021): $11K with participation from PPP
Key Investors in ZeroSweat
PPP
Public-Private Partnership
What's next for ZeroSweat?
The influx of growth capital is expected to accelerate ZeroSweat's market penetration and product development pipeline. Moving forward, the company is well-positioned to scale its distribution channels and enhance its digital footprint to reach a broader audience suffering from sweat-related conditions. By leveraging this financial backing, ZeroSweat aims to optimize its supply chain and potentially expand its research into advanced dermatological formulations. The strategic focus remains on maintaining high customer retention rates while capturing additional market share within the competitive personal care landscape, ensuring long-term sustainability and brand equity growth.
See full ZeroSweat company page
